DREADD
Designer receptors exclusively activated by designer drugs (DREADDs) are genetically engineered GPCRs that are activated by physiologically inert synthetic small molecules (designer drugs) but not their endogenous ligand. Read our DREADDs mini-review or for practical advice on using these ligands in the lab see Stability of Water-Soluble DREADD Ligands in Solution: A Technical Review and Clozapine N-Oxide (freebase) - a technical review on stability, solubility and use in the lab).
EHNA hydrochloride (HB3540)
Description:Potent adenosine deaminase and PDE2 inhibitor. Supresses spontaneous hESC differentiation. Also maintains pluripotency of hESCs in the absence of exogenous cytokines.
Purity:>98%
-
-
Eliprodil (HB0274)
Description:Non-competitive, GluN2B subunit selective NMDA receptor antagonist
Purity:>98%
-
-
Empagliflozin (HB4638)
Description:Potent, selective sodium glucose co-transporter 2 (SGLT-2) inhibitor
Purity:>98%
